Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
91.14 0.51 0.56%

Closed Market

91.65

+0.51 (0.56%)

Volume: 2.02M

Last Updated:

Jul 10, 2026, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$92.34

 Day Range

91.16 - 92.49

52 Week Range

67.33 - 92.49

 Market Cap

$58.65B

Shares Outstanding

643.44M

 Public Float

537.71M

Beta

0.78

 Rev. Per Employee

N/A

P/E Ratio

17.63

 EPS

$5.20

Yield

251.78%

 Dividend

$0.59

EX-DIVIDEND DATE

Aug 4, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

4.01M

  

MET Performance

1 Week
 
 1.21%
 
1 Month
 
 2.60%
 
3 Months
 
 23.38%
 
1 Year
 
 17.31%
 
5 Years
 
 54.86%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 95.133
Number of Ratings 22 Current Quarters Estimate 2.534
FY Report Date 09 / 2026 Current Year's Estimate 9.91
Last Quarter’s Earnings 2.33 Median PE on CY Estimate N/A
Year Ago Earnings 8.83 Next Fiscal Year Estimate 11.00
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 17 18 18
Mean Estimate 2.53 2.59 9.91 11.00
High Estimates 2.69 2.80 10.55 11.63
Low Estimate 2.41 2.38 9.55 10.60
Coefficient of Variance 2.52 3.86 2.22 2.64

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 12 12
OVERWEIGHT 3 2 2
HOLD 6 6 7
UNDERWEIGHT 2 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Mar 13, 2026 William E. Kennard Director 45,780 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 3,232,068.00
Mar 13, 2026 Robert Glenn Hubbard Director 104,630 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 7,386,878.00
Mar 13, 2026 Christian Mumenthaler Director 2,125 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 150,025.00
Mar 13, 2026 Carla A. Harris Director 9,764 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 689,338.40
Mar 13, 2026 Diana L. McKenzie Director 23,751 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 1,676,820.60
Mar 13, 2026 Jeh Charles Johnson Director 8,129 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 573,907.40
Mar 13, 2026 Laura J. Hay Director 4,971 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 350,952.60

Metlife Inc. in the News